Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis

Atherosclerosis

Volumn 131, Issue 2, 1997, Pages 229-236

  Shoji, Tetsuo ^a   Nishizawa, Yoshiki ^a   Kawagishi, Takahiko ^a   Tanaka, Masaaki ^a   Kawasaki, Koichi ^a   Tabata, Tsutomu ^b   Inoue, Takashi ^b   Morii, Hirotoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

Author keywords

Cholesterol; Hemodialysis; Lipoprotein; Triglycerides; Uremia

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UREMIA;

ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 0031007046     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00054-3     Document Type: Article

References (33)

1. Kannel, WB, Castelli, WP, Gordon, T, McNamara PM. Serum cholesterol, lipoproteins and risk of coronary heart disease. The Framimgham Study. Ann Intern Med 1971;74:1-12.
2. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-2828.
3. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet 1975;1:16-19.
4. Gordon T, Castelli WP, Hjortland MC, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-714.
5. Tatami R, Mabuchi H, Ueda R, Haba T, Kametani T, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayama A, Kanaya H, Oiwake H, Genda A, Takeda R. Intermediate-density lipoprotein and cholesterol rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 1981;64:1174-1184.
6. Kameda K, Matsuzawa Y, Kubo M, Ishikawa K, Maejima L, Yamamura T, Yamamoto A, Tarui S. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis 1984;51:241-249.
7. Krauss RM, Lindgren FT, Williams PT, Kelsey SF, Brensike J, Vranizan K, Detre KM, Levy R. Intermediate-density lipoproteins and progression of coronary disease in hypercholesterolaemic men. Lancet 1987;2:62-66.
8. Watts GF, Mandelia S, Bruns JNH, Slavin BM, Coitart DJ, Lewis B. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St Thomas' Atherosclerosis regression study (STARS). Metabolism 1993;42:1461-1467.
9. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993;88:2762-2770.
10. Drexel H, Amann FW, Beran J, Rentsch K, Candinas R, Muntwyler J, Luethy A, Gasser T, Follath F. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994;90:2230-2235.
11. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Cahmeton AH, Tweedie-Hardman J, Kotite L Kunitake ST, Havel RJ, Kane JP. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 1994;14:1767-1774.
12. Mack WJ, Krauss RM, Hodis HN. Lipoprotein subclasses in the Monitored Atherosclerosis regression study (MARS): Treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vase Biol 1996;16:697-704.
13. Lindner A, Charra B, Sherrard DJ, Scriboer BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
14. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in the chronic renal failure and hemodialysis population. Am J Kidney Dis 1992;19:505-513.
15. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995;48:820-826.
16. Attman P-O, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993;21:573-592.
17. Bagdade JD, Porte D Jr, Bierman EL. Hypertriglyceridemia: A metabolic consequence of chronic renal failure. N Engl J Med 1968;279:181-185.
18. Ron D, Oren L, Aviram M, Better OS, Brook JG. Accumulation of lipoprotein remnants in patients with chronic renal failure. Atherosclerosis 1983;46:67-75.
19. Bronzert TJ, Brewer HB, Jr. New micromethod for measuring cholesterol in plasma lipoprotein fractions. Clin Chem 1977;23:2089-2098.
20. Muniz N. Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel. Clin Chem 1977;23:1826-1833.
21. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifuially separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
22. Ichihara K. Statistics for Bio science. Practical Technique and Theory. Tokyo: Nankodo Co. Ltd, 1990, pp. 218-223.
23. The expert panel: Summary of the second report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA 1993;269:3015-3023.
24. Kasama T, Yohino G, Iwatani L, Iwai M, Hatanaka H, Kazumi, Oimomi M, Baba S. Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic noninsulin-dependent diabetics. Atherosclerosis 1987;63:263-266.
25. Nestel PJ, Fidge NH, Tan MH. Increased lipoprotein remnant formation in chronic renal failure. N Engl J Med 1982;307:329-333.
26. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired high density lipoprotein metabolism in uremic patients. Kidney Int 1992;41:1653-1661.
27. Nishizawa Y, Shoji T, Emoto M, Kawasaki K, Konishi T, Tabata T, Inoue T, Morii H. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients. Clin Nephrol 1995;43:268-277.
28. Attman P-O, Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int 1991;39(Suppl):S16-S23.
29. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis. Metabolism 1991;40:1002-1008.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
31. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993;34:1687-1697.
32. Austin MA, Breslow JL, Hannekens CH, Buring JE, Willett WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988;260:1917-1921.
33. Shoji T, Nishizawa Y, Kawagishi T, Morii H. Secondary hyperparathyroidism, increased IDL and atherosclerosis in hemodialysis patients. Nephron (in press).